TGA Reforms 2024: What Medical Device Companies Need to Know
Recent TGA regulatory reforms are reshaping the landscape for medical device companies operating in Australia. Here is what you need to prepare for.
The Therapeutic Goods Administration continues to evolve its regulatory framework to ensure Australian patients have access to safe and effective medical devices. Recent reforms have introduced significant changes that manufacturers and sponsors must understand.
Key reform areas include enhanced post-market surveillance requirements, updated classification rules aligned with international standards, and strengthened requirements for clinical evidence. These changes reflect Australia's commitment to maintaining one of the world's most robust regulatory systems.
Manufacturers should pay particular attention to the updated requirements for Software as a Medical Device (SaMD), which now has clearer classification criteria and conformity assessment pathways.